Person

Back to overview Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

In vivo dynamics of HIV-1 virological parameters; implications for diagnosis and evaluation of therapeutic efficacy
Perrin Luc H. University of Geneva - GE 01.04.1993 31.03.1996 Project funding (special)

Treatment of Primary HIV Infection (PHI).
Perrin Luc H. University of Geneva - GE 01.04.1995 31.03.1998 Project funding (special)

"Characterisation of P. falciparum asexual bloos stage anti- gens and their use in immunisation studies."
Perrin Luc H. University of Geneva - GE 01.10.1985 30.09.1987 Project funding

Characterisation of P. falciparum polypeptides susceptible to induce a protective immune response
Perrin Luc H. University of Geneva - GE 01.04.1982 30.09.1983 Project funding

Caractérisation des antigènes malariens induisant une réponse immune protectrice
Perrin Luc H. University of Geneva - GE 01.04.1980 31.03.1982 Project funding

Characterisation of Plasmodium falciparum asexual blood stages: immunisation and immune response
Perrin Luc H. University of Geneva - GE 01.10.1987 30.09.1989 Project funding

Primary HIV-1 Infection in the context of an evolving epidemic and therapeutic interventions.
Perrin Luc H. University of Geneva - GE 01.04.2001 31.03.2004 Project funding (special)

Characterisation of Plasmodium falciparum asexual blood stages: immunisation and immune response
Perrin Luc H. University of Geneva - GE 01.10.1989 30.09.1991 Project funding

Characterisation of malarial antigens and their potential use in vaccination studies
Perrin Luc H. University of Geneva - GE 01.10.1983 30.09.1985 Project funding

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

A new reporter cell line to monitor HIV infection and phenotypic resistance to antiretroviral drugs
Gervaix Alain University of Geneva - GE 01.04.1998 31.03.2002 Project funding (special)

A Comprehensive Program for the Evaluation of Treatment Failure
Telenti Amalio University of Lausanne - LA 01.01.2000 30.04.2000 Project funding (special)

SITT-2: Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)plus treatment interruptions for stimulating anti-HIV immune response
Hirschel Bernard University of Geneva - GE 01.07.2001 30.09.2002 Project funding (special)

-